Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Marquette National Corporation Reports 2025 Annual Results
-
MEXC Foundation Returns as Title Sponsor of Korea University's 2026 AI & Blockchain Business Model Ideathon
-
Norsk Hydro: Hydro to close extrusion plant in Lucé, France
-
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Sunlands Technology Group to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
-
Director/PDMR Shareholding
-
Nokia expands Network as Code ecosystem, advances API-based agentic AI with Google Cloud #MWC26
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Form 8.3 - [IDOX PLC - 02 03 2026] - (CGWL)
-
Retail Bank Executes Expanded $1.04M License Renewal for BIO-key Biometric Identity Solution Serving 30M Clients
-
Downward adjustment of expectations for the financial year 2025/26 - Roblon to publish new 2030-strategy by the end of March 2026
-
Circuits Integrated Announces CI-ONE Family of Ka-Band Integrated Switch Power Amplifiers, Enabling Ultra-Compact, Cost-Optimized Satcom Architectures
-
Xtrim Selects Qvantel to Modernise BSS
-
Revenium Launches Tool Registry to Bring Economic Accountability to AI Agents Deployments
-
Green Building Initiative Launches Ascent Building Certification™ for Global Markets
-
Alephium Launches Core dApp, “Powfi” on Testnet, Progressing ‘Phase Two’ of Its Aligned Economics Vision
-
PONY AI Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 26, 2026
-
Kalmar Corporation’s conveyance of own shares based on the long-term incentive plans
-
Quell Therapeutics Initiates CHILL Phase 1/2 Trial of Novel QEL-005 CAR-Treg Therapy in Refractory Rheumatoid Arthritis and Systemic Sclerosis Following UK CTA Approval
-
SHERPA research consortium initiates seven clinical studies to validate AI-based assistive technologies for minimally invasive brain and cancer treatments
-
17/2026・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
-
Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study
-
Half of Young Adults Have Had to Move Back in with Mum and Dad, in a Bid to Save Cash, According to a New Report by Access Self Storage
-
Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program – End of Buyback
-
16/2026・Trifork Group: Share-based incentive program 2026
-
Ride the XRP Wave at Bitrue With a 70,000 XRP Trading Contest
-
Quantexa Showcases How Decision Intelligence Powers the Next Generation of AI-Driven Organizations at QuanCon 2026
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Charles IT, a Connecticut-Based Managed Service Provider Achieves CMMC Level 2 Certification, Positioning Defense Contractors to Meet Looming Federal Compliance Deadlines
-
Hogan Lovells Partners with LawFairy to Launch Legal Intelligence System Supporting Undocumented Children's Immigration Cases
-
Lantronix Expands European Distribution Footprint Through Strategic Partnership With Melchioni Electronics
-
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
-
Multiverse Computing Launches CompactifAI APP, Bringing Offline AI to Edge Devices
-
Huhtamaki's 2025 Annual Report published
-
Municipality Finance issues a USD 25 million tap under its MTN programme
-
From Track to Pitch: Zoomex Teams Up with TGR Haas F1 Team and Emiliano Martínez to Launch Its 2026 Road to the Championship
-
Zoomex Announces Strategic Upgrade to Core Trading Infrastructure, Strengthening Execution Standards for 2026
-
Havila Finans AS: Fourth quarter 2025 accounts
-
ARGAN'S 2025 UNIVERSAL REGISTRATION DOCUMENT MADE AVAILABLE
-
Quadient Strengthens Position as a Global Software Leader as CEO Takes Direct Leadership of Digital Automation Platform Business
-
Montis Biosciences Advances First-in-Class Dual-Action C1q Antibody with Strong Preclinical Proof-of-Concept in Neuroinflammatory Diseases
-
US Investor Briarwood Chase Management Doubles Its Stake in Sidetrade, Crossing 10% of Capital
-
ING completes share repurchase for employee compensation
-
MT Højgaard Holding A/S: Niels Holm Mikkelsen new CEO of MT Højgaard Danmark
-
Casino Group Communication
-
OSB GROUP PLC - Transaction in Own Shares
-
NBPE Announces Transaction in Own Shares
-
Director Declaration
-
Equinor ASA: Share buy-back – first tranche for 2026

